Guest

Andrew Huberman

Organizations

Huberman Labfounder, co-founder, host

Interviews

Andrew Huberman joins TBPN: retreutide, peptide legality, cannabis psychosis risk, and Olympic athlete biohacking

Andrew Huberman on proposed 40% NIH budget cuts: 'You can't overstate the importance of NIH funding basic and applied research'

Mentions

Peptide debate recap: Silicon Valley's gray market drug craze — psychology or science?

Rob Mohr on building Huberman Lab: the business of science-based health content at scale